CTXR — Citius Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-08-03.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2024-03-13 | Holuka Eugene Myron Director | Option exercise | 2.4K | 0.02 | 48 |
| 2024-03-13 | Holuka Eugene Myron Director | Shares withheld for tax | 48 | 0.75 | 36 |
| 2024-03-04 | Webb Carol Director | Option exercise | 12.1K | 0.02 | 241 |
| 2024-03-04 | Webb Carol Director | Shares withheld for tax | 236 | 0.77 | 182 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 221.6K | 246.2K |
| VANGUARD CAPITAL MANAGEMENT LLC | 151.0K | 167.7K |
| VANGUARD FIDUCIARY TRUST CO | 70.0K | 77.8K |
| BlackRock, Inc. | 62.9K | 69.9K |
| Asset Advisory Group, Inc. | 53.1K | 59.0K |
| UBS Group AG | 49.5K | 55.0K |
| NORTHERN TRUST CORP | 39.6K | 44.0K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 33.2K | 36.8K |
| LPL Financial LLC | 22.5K | 25.0K |
| STATE STREET CORP | 20.9K | 23.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 8-K | 2026-08-05 | 2026-08-05 | on EDGAR ↗ |
| EFFECT | 2026-06-02 | — | on EDGAR ↗ |
| 8-K | 2026-06-01 | 2026-06-01 | on EDGAR ↗ |
| S-3 | 2026-05-22 | — | on EDGAR ↗ |
| 8-K | 2026-05-15 | 2026-05-15 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Citius Pharmaceuticals, Inc. (CTXR) filed form 8-K · 2026-08-21 · SEC EDGAR
- Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M · 2026-08-17
- Citius Pharmaceuticals, Inc. (CTXR) filed form 8-K · 2026-08-14 · SEC EDGAR
- Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update · 2026-08-14
- Citius Pharmaceuticals, Inc. (CTXR) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Citius Pharmaceuticals, Inc. (CTXR) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about CTXR
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →